Specificity protein 1 expression contributes to Bcl-w-induced aggressiveness in glioblastoma multiforme

Molecules and Cells

Volumn 37, Issue 1, 2014, Pages 17-23

  Lee, Woo Sang ^a   Kwon, Junhye ^b   Yun, Dong Ho ^a   Lee, Young Nam ^a   Woo, Eun Young ^a   Park, Myung Jin ^a   Lee, Jae Seon ^a   Han, Young Hoon ^a   Bae, In Hwa ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Sookmyung Women's University   (South Korea)

Author keywords

Aggressiveness; Bcl w; Glioblastoma multiforme; Glioma stem cell markers; Invasion; Sp1

Indexed keywords

CELL MARKER; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN BCL W; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MUSASHI; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BCL2L2 PROTEIN, HUMAN; GELATINASE A; MMP2 PROTEIN, HUMAN; SP1 PROTEIN, HUMAN;

ARTICLE; CANCER GRADING; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; WESTERN BLOTTING; CANCER STEM CELL; ENZYME ACTIVATION; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; ENZYME ACTIVATION; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; SP1 TRANSCRIPTION FACTOR; SPHEROIDS, CELLULAR;

EID: 84901457154     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2014.2161     Document Type: Article

References (30)

1. Abdelrahim, M., Smith, R., 3rd, Burghardt, R., and Safe, S. (2004). Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res. 64, 6740-6749. (Pubitemid 39297937)
2. Bae, I.H., Park, M.J., Yoon, S.H., Kang, S.W., Lee, S.S., Choi, K.M., and Um, H.D. (2006). Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Cancer Res. 66, 4991-4995. (Pubitemid 43844917)
3. Bae, I.H., Yoon, S.H., Lee, S.B., Park, J.K., Ho, J.N., and Um, H.D. (2009). Signaling components involved in Bcl-w-induced migration of gastric cancer cells. Cancer Lett. 277, 22-28.
4. Chiefari, E., Brunetti, A., Arturi, F., Bidart, J.M., Russo, D., Schlumberger, M., and Filetti, S. (2002). Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation? BMC Cancer 2, 35-38.
5. Chuang, J.Y., Wu, C.H., Lai, M.D., Chang, W.C., and Hung, J.J. (2009). Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells. Int. J. Cancer 125, 2066-2076.
6. Chuang, Y.S., Huang, W.H., Park, S.W., Persaud, S.D., Hung, C.H., Ho, P.C., and Wei, L.N. (2011). Promyelocytic leukemia protein in retinoic acid-induced chromatin remodeling of Oct4 gene promoter. Stem Cells 29, 660-669.
7. Davie, J.R., He, S., Li, L., Sekhavat, A., Espino, P., Drobic, B., Dunn, K.L., Sun, J.M., Chen, H.Y., Yu, J., et al. (2008). Nuclear organization and chromatin dynamics-Sp1, Sp3 and histone deacetylases. Adv. Enzyme Regul. 48,189-208.
8. Duan, P., Zhang, Y., Han, X., Liu, J., Yan, W., and Xing, Y. (2012). Effect of neuronal induction on NSE, Tau, and Oct4 promoter methylation in bone marrow mesenchymal stem cells. In vitro cellular & developmental biology. Animal 48, 251-258.
9. Furnari, F.B., Fenton, T., Bachoo, R.M., Mukasa, A., Stommel, J.M., Stegh, A., Hahn, W.C., Ligon, K.L., Louis, D.N., Brennan, C., et al. (2007). Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21, 2683-2710. (Pubitemid 350070717)
10. Guan, H., Cai, J., Zhang, N., Wu, J., Yuan, J., Li, J., and Li, M. (2011). Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome. Int. J. Cancer 130, 593-601.
11. Hoelzinger, D.B., Mariani, L., Weis, J., Woyke, T., Berens, T.J., Mc-Donough, W.S., Sloan, A., Coons, S.W., and Berens, M.E. (2005). Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7, 7-16. (Pubitemid 40209466)
12. Jungert, K., Buck, A., von Wichert, G., Adler, G., Konig, A., Buchholz, M., Gress, T.M., and Ellenrieder, V. (2007). Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells. Cancer Res. 67, 1563-1570. (Pubitemid 46383380)
13. Katoh, Y., and Katoh, M. (2007). Conserved POU-binding site linked to SP1-binding site within FZD5 promoter: Transcriptional mechanisms of FZD5 in undifferentiated human ES cells, fetal liver/spleen, adult colon, pancreatic islet, and diffuse-type gastric cancer. Int. J. Oncol. 30, 751-755.
14. Kong, L.M., Liao, C.G., Fei, F., Guo, X., Xing, J.L., and Chen, Z.N. (2010). Transcription factor Sp1 regulates expression of cancer-associated molecule CD147 in human lung cancer. Cancer Sci. 101, 1463-1470.
15. Kumar, A.P., and Butler, A.P. (1999). Enhanced Sp1 DNA-binding activity in murine keratinocyte cell lines and epidermal tumors. Cancer Lett. 137, 159-165. (Pubitemid 29179459)
16. Lee, H.W., Lee, S.S., Lee, S.J., and Um, H.D. (2003). Bcl-w is expressed in a majority of infiltrative gastric adenocarcinomas and suppresses the cancer cell death by blocking stress-activated protein kinase/c-Jun NH2-terminal kinase activation. Cancer Res. 63, 1093-1100. (Pubitemid 36278443)
17. Lee, W.S., Woo, E.Y., Kwon, J., Park, M.J., Lee, J.S., Han, Y.H., and Bae, I.H. (2013). Bcl-w enhances mesenchymal changes and invasiveness of glioblastoma cells by inducing nuclear accumulation ofβ - catenin. PLoS One 8, e68030.
18. Lou, Z., O'Reilly, S., Liang, H., Maher, V.M., Sleight, S.D., and McCormick, J.J. (2005). Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation. Cancer Res. 65, 1007-1017. (Pubitemid 40216463)
19. Safe, S., and Abdelrahim, M. (2005). Sp transcription factor family and its role in cancer. Eur. J. Cancer 41, 2438-2448. (Pubitemid 41540621)
20. Shi, Q., Le, X., Abbruzzese, J.L., Peng, Z., Qian, C.N., Tang, H., Xiong, Q., Wang, B., Li, X.C., and Xie, K. (2001). Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 61, 4143-4154. (Pubitemid 32720983)
21. Shin, J.E., Park, S.H., and Jang, Y.K. (2011). Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer. Mol. Cells 31, 181-189.
22. Simonsson, S., and Gurdon, J. (2004). DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat. Cell Biol. 6, 984-990. (Pubitemid 39359851)
23. Wang, L., Wei, D., Huang, S., Peng, Z., Le, X., Wu, T.T., Yao, J., Ajani, J., and Xie, K. (2003). Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin. Cancer Res. 9, 6371-6380. (Pubitemid 38031822)
24. Wang, L., Guan, X., Gong, W., Yao, J., Peng, Z., Wei, D., Wu, T.T., Huang, S., and Xie, K. (2005). Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer. Clin. Exp. Metastasis 22, 205-213. (Pubitemid 41298002)
25. Wei, D., Wang, L., He, Y., Xiong, H.Q., Abbruzzese, J.L., and Xie, K. (2004). Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res. 64, 2030-2038. (Pubitemid 38339450)
26. Wilson, J.W., Nostro, M.C., Balzi, M., Faraoni, P., Cianchi, F., Becciolini, A., and Potten, C.S. (2000). Bcl-w expression in colorectal adenocarcinoma. Br. J. Cancer 82, 178-185. (Pubitemid 30008979)
27. Wu, D.Y., and Yao, Z. (2006). Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter. Cell Res. 16, 319-322.
28. Yang, H.M., Do, H.J., Oh, J.H., Kim, J.H., Choi, S.Y., Cha, K.Y., and Chung, H.M. (2005). Characterization of putative cis-regulatory elements that control the transcriptional activity of the human Oct4 promoter. J. Cell Biochem. 96, 821-830.
29. Yao, J.C., Wang, L., Wei, D., Gong, W., Hassan, M., Wu, T.T., Mansfield, P., Ajani, J., and Xie, K. (2004). Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin. Cancer Res. 10, 4109-4117. (Pubitemid 38812490)
30. Zannetti, A., Del Vecchio, S., Carriero, M.V., Fonti, R., Franco, P., Botti, G., D'Aiuto, G., Stoppelli, M.P., and Salvatore, M. (2000). Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res. 60, 1546-1551. (Pubitemid 30183423)